HUM
Price
$417.42
Change
-$0.45 (-0.11%)
Updated
Nov 4 closing price
Capitalization
50.12B
One day until earnings call
Intraday BUY SELL Signals
MOH
Price
$226.42
Change
+$18.57 (+8.93%)
Updated
Nov 4 closing price
Capitalization
11.82B
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HUM vs MOH

HUM vs MOH Comparison Chart in %
View a ticker or compare two or three
VS
HUM vs. MOH commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HUM is a Hold and MOH is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HUM with price predictions
Nov 04, 2026

HUM in downward trend: price may decline as a result of having broken its higher Bollinger Band on October 09, 2026

HUM broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In 29 of the 37 cases the stock fell afterwards. This puts the odds of success at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for HUM moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 21 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HUM as a result. In 47 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The Moving Average Convergence Divergence Histogram (MACD) for HUM turned negative on October 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 33 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HUM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 53 cases where HUM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.

HUM moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HUM crossed bullishly above the 50-day moving average on October 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where HUM advanced for three days, in 218 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 4 (best 1 - 100 worst), indicating outstanding price growth. HUM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.609) is normal, around the industry mean (3.512). P/E Ratio (39.084) is within average values for comparable stocks, (126.100). HUM's Projected Growth (PEG Ratio) (1.304) is slightly higher than the industry average of (0.786). Dividend Yield (0.008) settles around the average of (0.009) among similar stocks. P/S Ratio (0.319) is also within normal values, averaging (0.569).

The Tickeron Profit vs. Risk Rating rating for this company is 93 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HUM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for MOH with price predictions
Nov 04, 2026

Momentum Indicator for MOH turns positive, indicating new upward trend

MOH saw its Momentum Indicator move above the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In 64 of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 52 cases where MOH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for MOH just turned positive on November 04, 2026. Looking at past instances where MOH's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.

MOH moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MOH crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Following a +4.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOH advanced for three days, in 210 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

The Aroon Indicator entered an Uptrend today. In 151 of 222 cases where MOH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

MOH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 22 (best 1 - 100 worst), indicating outstanding price growth. MOH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.834) is normal, around the industry mean (3.512). MOH's P/E Ratio (1415.125) is considerably higher than the industry average of (126.100). Projected Growth (PEG Ratio) (0.880) is also within normal values, averaging (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.233) is also within normal values, averaging (0.569).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
HUM vs MOH: Fundamental Ratings
HUM
MOH
OUTLOOK RATING
1..100
7732
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
9890
PRICE GROWTH RATING
1..100
422
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
5039

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HUM's Valuation (78) in the Managed Health Care industry is in the same range as MOH (99). This means that HUM’s stock grew similarly to MOH’s over the last 12 months.

HUM's Profit vs Risk Rating (93) in the Managed Health Care industry is in the same range as MOH (100). This means that HUM’s stock grew similarly to MOH’s over the last 12 months.

MOH's SMR Rating (90) in the Managed Health Care industry is in the same range as HUM (98). This means that MOH’s stock grew similarly to HUM’s over the last 12 months.

HUM's Price Growth Rating (4) in the Managed Health Care industry is in the same range as MOH (22). This means that HUM’s stock grew similarly to MOH’s over the last 12 months.

MOH's P/E Growth Rating (1) in the Managed Health Care industry is in the same range as HUM (6). This means that MOH’s stock grew similarly to HUM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HUMMOH
RSI
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 16 days ago
63%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 8 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
COMPARISON
Comparison
Nov 05, 2026
Stock price -- (HUM: $417.42 vs. MOH: $226.42)
Brand notoriety: HUM: Notable vs. MOH: Not notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: HUM: 145% vs. MOH: 260%
Market capitalization -- HUM: $50.12B vs. MOH: $11.82B
HUM [@Managed Health Care] is valued at $50.12B. MOH’s [@Managed Health Care] market capitalization is $11.82B. The market cap for tickers in the [@Managed Health Care] industry ranges from $335.99K to $367.46B. The average market capitalization across the [@Managed Health Care] industry is $68.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HUM’s FA Score shows that 2 FA rating(s) are green while MOH’s FA Score has 2 green FA rating(s).

  • HUM’s FA Score: 2 green, 3 red.
  • MOH’s FA Score: 2 green, 3 red.
According to our system of comparison, both HUM and MOH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HUM’s TA Score shows that 4 TA indicator(s) are bullish while MOH’s TA Score has 7 bullish TA indicator(s).

  • HUM’s TA Score: 4 bullish, 5 bearish.
  • MOH’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, MOH is a better buy in the short-term than HUM.

Price Growth

HUM (@Managed Health Care) experienced а +1.56% price change this week, while MOH (@Managed Health Care) price change was +14.30% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was +4.35%. For the same industry, the average monthly price growth was +7.51%, and the average quarterly price growth was +19.94%.

Reported Earning Dates

HUM is expected to report earnings on Nov 06, 2026.

MOH is expected to report earnings on Feb 10, 2027.

Industries' Descriptions

@Managed Health Care (+4.35% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.